Norvasc - Medsafe
NORVASC® 1 Norvasc® Amlodipine (am-load-i-peen) Besilate Consumer Medicine Information . What is in this leaflet Norvasc is not for …
Download Norvasc - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
DRUGS AND COSMETICS (2 ND AMENDMENT) …
rajswasthya.nic.inDRUGS AND COSMETICS (2 ND AMENDMENT) RULES, 2006 MINISTRY OF HEALTH AND FAMILYWELFARE (Department of Health) NOTIFICATION New Delhi, the 16th March, 2006 G.S.R. 160(E).– Whereas a draft of …
CRÍTICA A LA PUBLICIDAD DE …
www.osakidetza.euskadi.eusCOMITÉ DE EVALUACIÓN DE NUEVOS MEDICAMENTOS DE EUSKADI CRÍTICA A LA PUBLICIDAD DE ZANIPRESS ®, LERCAPRESS ®, CORIPREN ® (Enalapril/Lercanidipino) www.osanet ...
ATC/DDD classification - WHO
www.who.intATC/DDD classification WHO Drug Information Vol. 29, No. 4, 2015 496 ATC/DDD classification The Anatomical Therapeutic Chemical (ATC) classification system and the Defined Daily Dose (DDD) as a measuring unit are tools for …
Schedule of Pharmaceutical Benefits - Minfos
www.minfos.com.au2 Schedule of Pharmaceutical Benefits – September 2018 Fees, Patient Contributions and Safety Net Thresholds The following fees, patient contributions and safety net thresholds apply as at 1 September 2018 and are included, where
The Renal Drug Handbook - pharmalink.nl
www.pharmalink.nlThe Renal Drug Handbook Third EdiTion Edited by Caroline Ashley and Aileen Currie UK Renal Pharmacy Group Foreword by Dr Aine Burns radcliffe Publishing